MOTIVATE increases device-measured moderate-to-vigorous physical activity (MVPA) at 3 and 6 months among community-dwelling stroke survivors compared with general PA information.
The MOTIVATE trial is a hybrid type 1 effectiveness-implementation randomized controlled trial testing a theory-informed, co-designed behavior change intervention to increase physical activity after stroke. The primary outcome is average daily minutes of moderate-to-vigorous physical activity (MVPA) measured by Fitbit Inspire 3 at 3 and 6 months. The trial aims to recruit 120 participants to detect a 10-minute/day difference in MVPA with 80% power, allowing for 20% attrition.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
MOTIVATE increases device-measured moderate-to-vigorous physical activity (MVPA) at 3 and 6 months among community-dwelling stroke survivors compared with general PA information. The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 44/100 (low).
The Claim
MOTIVATE increases device-measured moderate-to-vigorous physical activity (MVPA) at 3 and 6 months among community-dwelling stroke survivors compared with general PA information.
This conclusion is most relevant to: Community-dwelling stroke survivors aged ≥21 years, ≥6 months post-stroke, ambulant with or without an aid..
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Multi-mOdal training program to promote physical actIVity after sTrokE (MOTIVATE): Protocol for effectiveness and economic outcomes in a hybrid type 1 effectiveness-implementation randomised controlled trial. (Contemporary clinical trials, 2026) —
How It Works
The proposed biological pathway:
- ▸MOTIVATE intervention delivered to stroke survivors
- ▸Behavior change techniques target self-efficacy, fatigue, mood, and sleep
- ▸Increased motivation and capability to engage in physical activity
- ▸Increased daily MVPA at 3 and 6 months
Who Might Benefit
Evidence fit by population:
- ▸Community-dwelling stroke survivors aged ≥21 years, ≥6 months post-stroke, ambulant with or without an aid.
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Protocol paper; results not yet available, so effectiveness is not confirmed.
- ▸Primary outcome relies on Fitbit device, which may have measurement error or adherence issues.
- ▸Sample size calculation assumes 20% attrition, which may affect power if attrition is higher.
Frequently Asked Questions
What is the MOTIVATE intervention?▼
MOTIVATE is a theory-informed, co-designed behavior change intervention to promote physical activity after stroke, delivered to community-dwelling stroke survivors.
How is physical activity measured in the MOTIVATE trial?▼
Physical activity is measured using a Fitbit Inspire 3 device, which records daily minutes of moderate-to-vigorous physical activity (MVPA).
Who is eligible for the MOTIVATE trial?▼
Adults aged 21 years or older, at least 6 months post-stroke, living at home, and able to walk with or without an aid.
What is the primary outcome of the MOTIVATE trial?▼
The primary outcome is the average daily minutes of moderate-to-vigorous physical activity (MVPA) at 3 and 6 months post-randomization.
References
- 1.Thilarajah S, Hao PY, De Silva DA, Thumboo J, Leng LL, Hollis J, Bird ML, Clark RA, Wang J, Kaur P, Khim KL. “Multi-mOdal training program to promote physical actIVity after sTrokE (MOTIVATE): Protocol for effectiveness and economic outcomes in a hybrid type 1 effectiveness-implementation randomised controlled trial..” Contemporary clinical trials, 2026. PMID: 42632450 DOI: 10.1016/j.cct.2026.108441